One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1200/jco.2016.34.15_suppl.lba506
Copy DOI
Export
Save
Share
Cite Journal: Journal of Clinical Oncology |  Publication Date: May 20, 2016 |
 Citations: 1 |
Affiliation: The Quebec Population Health Research Network, Massachusetts General Hospital, Queen's University, Cancer Care Ontario, Sunnybrook Health Science Centre, University of North Carolina Health Care, University of North Carolina at Chapel Hill, Wilhelminen Hospital, Mayo Clinic, The US Oncology Network, Seattle Cancer Care Alliance, University of Washington
Patient-reported outcomes from MA.17R: A randomized trial of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
